What is Artemis Medicare Services Limited's latest revenue?

Artemis Medicare Services Limited reported revenue of ₹1,081 Cr in its latest annual results, per the filed results.

What is Artemis Medicare Services Limited's latest net profit?

Artemis Medicare Services Limited reported net profit of ₹104 Cr in its latest annual results, per the filed results.

What is Artemis Medicare Services Limited's return on equity?

Artemis Medicare Services Limited posted ROE of 12.2% and ROCE of 15.2% for its latest annual results, computed from filed statements.

What is Artemis Medicare Services Limited's operating margin?

Artemis Medicare Services Limited's operating margin was 15.4% in its latest annual results, derived from filed operating expenses.

How much did Artemis Medicare Services Limited's revenue grow year-on-year?

Artemis Medicare Services Limited's revenue changed 15.4% year-on-year in its latest annual results, per the filed results.

ART

ARTEMISMED

Name: Artemis Medicare Services Limited (ARTEMISMED) quarterly results & financial statements
Creator: Upmazing

Artemis Medicare Services Limited

HealthcareHealthcare Services

ISIN INE025R01021

—

Day

52W

MCap₹5,268 Cr

goodUpmazing Score

Open chart ↗

ART

ARTEMISMED

Artemis Medicare Services Limited

HealthcareHealthcare Services

ISIN INE025R01021

—

Day

52W

MCap₹5,268 Cr

goodUpmazing Score

Open chart ↗

Artemis Medicare Services Limited (ARTEMISMED) reported revenue of ₹287 Cr and net profit of ₹31.44 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.

ARTEMISMED fundamentals, Fundamental score 67/100

The statements below are read from Artemis Medicare Services Limited’s filed results, 24 filed quarters and 8 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.

Latest: Q1 FY26-27 · filed Aug 4, 2026 · audited

Sales CAGR · 3Y+13.6%FY22 → FY25

Sales CAGR · 4Y+18.2%FY21 → FY25

PAT CAGR · 3Y+39.7%FY22 → FY25

PAT CAGR · 4Y+34.8%FY21 → FY25

Price · 1Y+46.5%EOD

Price CAGR · 3Y+37.5%EOD

Quarterly resultsConsolidated

₹ Cr	Dec2018	Sep2019	Dec2019	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026Latest	YoYlatest
Sales	139	147	143	122	139	144	149	167	187	187	195	210	225	219	225	223	241	232	240	255	275	272	279	287	+12.7%
	130	139	136	109	119	126	132	148	164	162	170	182	191	186	187	187	199	195	204	214	224	228	228	231	+8.1%
Operating profit	—	—	—	13.0	19.7	17.7	17.1	19.2	23.5	25.6	25.7	27.9	34.2	32.6	38.0	36.2	42.3	37.5	35.9	41.4	50.6	44.6	51.6	56.4	+36.4%
OPM %	—	—	—	10.6%	14.2%	12.3%	11.4%	11.5%	12.5%	13.7%	13.1%	13.3%	15.2%	14.9%	16.8%	16.2%	17.5%	16.1%	15.0%	16.2%	18.4%	16.4%	18.5%	19.6%	+3.4 pp
Other income	0.63	1.24	0.72	0.80	0.86	1.00	1.24	2.31	1.41	1.24	2.38	1.25	2.42	1.78	1.90	4.40	7.44	8.80	12.3	6.93	7.65	7.46	7.79	5.37	-22.4%
Interest	—	—	—	2.39	2.69	3.19	3.71	4.32	4.90	5.19	5.27	6.87	7.88	7.96	8.57	8.13	7.98	8.00	7.83	7.38	7.19	6.75	6.37	6.46	-12.5%
Depreciation	—	—	—	5.07	5.15	5.58	6.39	6.59	7.31	8.36	8.73	9.17	9.95	10.2	11.0	10.8	11.2	11.5	11.7	11.2	11.7	12.4	12.8	12.7	+14.1%
Profit before tax	9.63	9.13	8.52	6.35	12.7	9.94	8.19	10.6	12.7	13.3	14.0	13.1	18.8	16.3	20.2	21.6	30.6	26.8	28.7	29.8	39.4	29.8	40.3	42.6	+43.1%
Tax %	49.0%	41.0%	34.4%	41.2%	36.3%	36.0%	-61.2%	22.1%	30.8%	22.7%	23.7%	25.6%	28.0%	29.2%	29.3%	23.6%	27.6%	23.2%	20.0%	28.8%	23.8%	25.3%	24.8%	26.2%	-2.6 pp
Net profit	4.91	5.38	5.59	3.74	8.09	6.36	13.2	8.27	8.77	10.3	10.7	9.75	13.5	11.6	14.3	16.5	22.1	20.6	22.9	21.2	30.0	22.2	30.3	31.4	+48.3%
EPS (₹)	—	—	—	2.93	0.62	0.49	—	0.64	0.68	0.78	0.79	0.72	1.00	0.85	1.04	1.14	1.42	1.32	1.47	1.35	1.90	1.41	1.90	1.98	+46.7%

One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters

Revenue & net profit trend

last 20 quarters

RevenueNet profit

Revenue & net profit — Consolidated20 quarters

Segment results

Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.

Forensic checksauto-scanned from the filing

Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.

How results moved the priceEOD reaction on the session the market could trade the filing

Avg absolute result-day move ±4.0%· EPS surprise: no estimates source· 2 earlier quarters have no dated filing on record

Q1'27filed Mon 3 Aug 17:21 · first tradeable session Tue 4 Auggap +0.9%close −0.1%

Q4'26filed Fri 8 May 20:39 · first tradeable session Mon 11 Maygap +2.4%close +5.8%

Q3'26filed Mon 2 Feb 20:10 · first tradeable session Tue 3 Febgap +2.3%close −9.2%

Q2'26filed Tue 11 Nov 18:35 · first tradeable session Wed 12 Novgap +2.0%close +6.8%

Q1'26filed Tue 5 Aug 17:34 · first tradeable session Wed 6 Auggap +0.3%close −0.9%

Q4'25filed Mon 12 May 17:43 · first tradeable session Tue 13 Maygap −1.4%close −2.1%

Q3'25filed Wed 5 Feb 13:38 · traded that sessiongap +0.8%close −6.7%

Q2'25filed Thu 14 Nov 18:54 · first tradeable session Mon 18 Novgap +1.8%close +0.0%

Q1'25filed Thu 8 Aug 15:48 · first tradeable session Fri 9 Auggap +0.9%close −0.5%

Q4'24filed Fri 10 May 18:36 · first tradeable session Mon 13 Maygap +3.0%close +1.4%

Q3'24filed Mon 5 Feb 17:18 · first tradeable session Tue 6 Febgap −0.1%close −4.1%

Q2'24filed Wed 8 Nov 18:02 · first tradeable session Thu 9 Novgap +1.5%close +3.6%

Q1'24filed Tue 8 Aug 16:29 · first tradeable session Wed 9 Auggap +2.0%close +1.2%

Q4'23filed Fri 5 May 18:32 · first tradeable session Mon 8 Maygap −0.5%close +8.1%

Q3'23filed Wed 1 Feb 13:58 · traded that sessiongap +1.3%close −3.5%

Q2'23filed Wed 9 Nov 17:31 · first tradeable session Thu 10 Novgap −3.5%close −2.2%

Q1'23filed Thu 11 Aug 16:30 · first tradeable session Fri 12 Auggap +2.8%close +7.1%

Q4'22filed Wed 11 May 18:44 · first tradeable session Thu 12 Maygap −4.8%close −7.1%

Q3'22filed Tue 1 Feb 17:36 · first tradeable session Wed 2 Febgap −4.3%close −4.5%

Q2'22filed Tue 26 Oct 17:00 · first tradeable session Wed 27 Octgap +5.0%close +5.0%

PeriodQ1 FY26-27BasisConsolidatedFiledAug 4, 2026Qualityaudited

Frequently Asked Questions

What is Artemis Medicare Services Limited's latest revenue?: Artemis Medicare Services Limited reported revenue of ₹1,081 Cr in its latest annual results, per the filed results.
What is Artemis Medicare Services Limited's latest net profit?: Artemis Medicare Services Limited reported net profit of ₹104 Cr in its latest annual results, per the filed results.
What is Artemis Medicare Services Limited's return on equity?: Artemis Medicare Services Limited posted ROE of 12.2% and ROCE of 15.2% for its latest annual results, computed from filed statements.
What is Artemis Medicare Services Limited's operating margin?: Artemis Medicare Services Limited's operating margin was 15.4% in its latest annual results, derived from filed operating expenses.
How much did Artemis Medicare Services Limited's revenue grow year-on-year?: Artemis Medicare Services Limited's revenue changed 15.4% year-on-year in its latest annual results, per the filed results.